PRESS RELEASE published on 11/04/2025 at 11:38, 3 months ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research initiates coverage on MaaT Pharma SACA with a BUY rating and EUR 17 price target. MaaT Pharma focuses on microbiome-based therapies for oncology, with high clinical impact and late-stage pipeline Oncology BUY Rating Clinical-stage Biotechnology MaaT Pharma SACA Microbiome-based Therapies
BRIEF published on 11/04/2025 at 07:35, 3 months ago MaaT Pharma Third Quarter 2025 Financial Results and Financing Update Financial Results MaaT Pharma European Medicines Agency Xervyteg® Clinigen Partnership
BRIEF published on 11/04/2025 at 07:35, 3 months ago MaaT Pharma : Résultats financiers et mise à jour du financement pour le troisième trimestre 2025 Résultats Financiers MaaT Pharma Agence Européenne Des Médicaments Xervyteg® Partenariat Clinigen
PRESS RELEASE published on 11/04/2025 at 07:30, 3 months ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma annonce ses activités de financement et résultats financiers T3 2025, incluant un accord avec Clinigen augmentant le CA de 45% Résultats Financiers Croissance Financement MaaT Pharma Accord Clinigen
PRESS RELEASE published on 11/04/2025 at 07:30, 3 months ago Inside Information / News release on accounts, results MaaT Pharma reports Q3 2025 financial results, secured financing, and partnership updates. Cash position of €22.4 million. Revenues increased by 45% year-over-year Revenues Financing Partnership MaaT Pharma Q3 2025
BRIEF published on 10/13/2025 at 14:52, 3 months 22 days ago Franchissement de Seuils par Invus Public Equities dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Invus Public Equities
BRIEF published on 10/13/2025 at 14:52, 3 months 22 days ago Crossing of Thresholds by Invus Public Equities in MAAT PHARMA Voting Rights Crossing Thresholds Transfer Of Shares MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/13/2025 at 14:47, 3 months 22 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities pour MAAT PHARMA avec 4,96% du capital et des droits de vote suite à une cession d'actions sur le marché Franchissement De Seuils Marché Cession D'actions MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/07/2025 at 07:30, 3 months 28 days ago Informations privilégiées / Autres communiqués
BRIEF published on 10/06/2025 at 14:59, 3 months 29 days ago Symbiosis LLC réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Symbiosis LLC
Published on 02/04/2026 at 16:15, 5 hours 4 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 5 hours 34 minutes ago Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 6 hours 19 minutes ago Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 20:54, 25 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 43 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 1 hour 19 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 2 hours 24 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 2 hours 39 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 3 hours 15 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 3 hours 15 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 3 hours 34 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 3 hours 34 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
